Evaluation of pneumonia virus of mice as a possible human pathogen

Journal of Virology

Volumn 86, Issue 10, 2012, Pages 5829-5843

  Brock, Linda G ^a   Karron, Ruth A ^b   Krempl, Christine D ^c   Collins, Peter L ^a   Buchholz, Ursula J ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN; IMMUNOGLOBULIN G; INTERFERON; VIRUS PROTEIN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY AFFINITY; ANTIBODY SPECIFICITY; ARTICLE; CHILD; CHLOROCEBUS; CONTROLLED STUDY; CROSS REACTION; CYTOKINE RESPONSE; EXPOSURE; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; MOUSE; MURINE PNEUMONIA VIRUS; NONHUMAN; PATHOGENESIS; PATHOGENICITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHESUS MONKEY; SEROPREVALENCE; VIRUS EXPRESSION; VIRUS NEUTRALIZATION; VIRUS REPLICATION; VIRUS SHEDDING; WESTERN BLOTTING;

ADULT; ANIMALS; ANTIBODIES, VIRAL; CELL LINE; CERCOPITHECUS AETHIOPS; CHILD, PRESCHOOL; CROSS PROTECTION; FEMALE; HUMANS; INFANT; MACACA MULATTA; MALE; MICE; MURINE PNEUMONIA VIRUS; PNEUMOVIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; VIRUS REPLICATION; YOUNG ADULT;

ANIMALIA; CERCOPITHECUS AETHIOPS; HUMAN RESPIRATORY SYNCYTIAL VIRUS; MACACA MULATTA; MURINE PNEUMONIA VIRUS; MUS; POTATO VIRUS M; PRIMATES; RICE STRIPE VIRUS;

EID: 84861309283     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00163-12     Document Type: Article

References (73)

1. Allander T, et al. 2005. Cloning of a human parvovirus by molecular screening of respiratory tract samples. Proc. Natl. Acad. Sci. U. S. A. 102: 12891-12896.
2. Anh DB, Faisca P, Desmecht DJ. 2006. Differential resistance/susceptibility patterns to pneumovirus infection among inbred mouse strains. Am. J. Physiol. Lung Cell. Mol. Physiol. 291:L426 -L435.
3. Barr J, Chambers P, Harriott P, Pringle CR, Easton AJ. 1994. Sequence of the phosphoprotein gene of pneumonia virus of mice: expression of multiple proteins from two overlapping reading frames. J. Virol. 68:5330-5334.
4. Becker SD, Bennett M, Stewart JP, Hurst JL. 2007. Serological survey of virus infection among wild house mice (Mus domesticus) in the UK. Lab. Anim. 41:229 -238.
5. Beeler JA, van Wyke Coelingh K. 1989. Neutralization epitopes of the F glycoprotein of respiratory syncytial virus: effect of mutation upon fusion function. J. Virol. 63:2941-2950.
6. Berthiaume L, Joncas J, Pavilanis V. 1974. Comparative structure, morphogenesis and biological characteristics of the respiratory syncytial (RS) virus and the pneumonia virus of mice (PVM). Arch. Gesamte Virusforsch. 45:39 -51.
7. Buchholz UJ, Finke S, Conzelmann KK. 1999. Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter. J. Virol. 73:251-259.
8. Buchholz UJ, et al. 2000. Chimeric bovine respiratory syncytial virus with glycoprotein gene substitutions from human respiratory syncytial virus (HRSV): effects on host range and evaluation as a live-attenuated HRSV vaccine. J. Virol. 74:1187-1199.
9. Buchholz UJ, et al. 2009. Deletion of nonstructural proteins NS1 and NS2 from pneumonia virus of mice attenuates viral replication and reduces pulmonary cytokine expression and disease. J. Virol. 83:1969 -1980.
10. Bukreyev A, et al. 2005. Recombinant Newcastle disease virus expressing a foreign viral antigen is attenuated and highly immunogenic in primates. J. Virol. 79:13275-13284.
11. Bukreyev A, et al. 2004. Mucosal immunisation of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS. Lancet 363:2122-2127.
12. Buttmann M, Berberich-Siebelt F, Serfling E, Rieckmann P. 2007. Interferon-beta is a potent inducer of interferon regulatory factor-1/2-dependent IP-10/CXCL10 expression in primary human endothelial cells. J. Vasc. Res. 44:51- 60.
13. Carthew P. 1978. Peroxidase-labeled antibody technique for rapid detection of mouse hepatitis virus in cases of natural outbreaks. J. Infect. Dis. 138:410-413.
14. Cash P, Preston CM, Pringle CR. 1979. Characterisation of murine pneumonia virus proteins. Virology 96:442- 452.
15. Chambers P, Barr J, Pringle CR, Easton AJ. 1990. Molecular cloning of pneumonia virus of mice. J. Virol. 64:1869 -1872.
16. Coates HV, Alling DW, Chanock RM. 1966. An antigenic analysis of respiratory syncytial virus isolates by a plaque reduction neutralization test. Am. J. Epidemiol. 83:299 -313.
17. Collins PL, Crowe JE. 2007. Respiratory syncytial virus and Metapneumovirus, p 1601-1646. In Knipe DM, HowleyPM(ed), Fields virology, vol 2, Lippincott, Williams and Wilkins, Philadelphia, PA.
18. Collins PL, et al. 1995. Production of infectious human respiratory syncytial virus from cloned cDNA confirms an essential role for the transcription elongation factor from the 5′ proximal open reading frame of the M2 mRNA in gene expression and provides a capability for vaccine development. Proc. Natl. Acad. Sci. U. S. A. 92:11563-11567.
19. Cook PM, Eglin RP, Easton AJ. 1998. Pathogenesis of pneumovirus infections in mice: detection of pneumonia virus of mice and human respiratory syncytial virus mRNA in lungs of infected mice by in situ hybridization. J. Gen. Virol. 79(Pt 10):2411-2417.
20. Dammann P, et al. 2011. Infectious microorganisms in mice (Mus musculus) purchased from commercial pet shops in Germany. Lab. Anim. 45:271-275.
21. Drosten C, et al. 2003. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N. Engl. J. Med. 348:1967-1976.
22. Easterbrook JD, Kaplan JB, Glass GE, Watson J, Klein SL. 2008. A survey of rodent-borne pathogens carried by wild-caught Norway rats: a potential threat to laboratory rodent colonies. Lab. Anim. 42:92-98.
23. Easton AJ, Domachowske JB, Rosenberg HF. 2004. Animal pneumoviruses: molecular genetics and pathogenesis. Clin. Microbiol. Rev. 17:390- 412.
24. Ehrenstein MR, Notley CA. 2010. The importance of natural IgM: scavenger, protector and regulator. Nat. Rev. Immunol. 10:778 -786.
25. Eisen HN, Chakraborty AK. 2010. Evolving concepts of specificity in immune reactions. Proc. Natl. Acad. Sci. U. S. A. 107:22373-22380.
26. Falsey AR, Walsh EE. 2000. Respiratory syncytial virus infection in adults. Clin. Microbiol. Rev. 13:371-384.
27. Gimenez HB, Cash P, Melvin WT. 1984. Monoclonal antibodies to human respiratory syncytial virus and their use in comparison of different virus isolates. J. Gen. Virol. 65(Pt 5):963-971.
28. Heinze B, et al. 2011. Both nonstructural proteins NS1 and NS2 of pneumonia virus of mice are inhibitors of the interferon type I and type III responses in vivo. J. Virol. 85:4071- 4084.
29. Hilkens CM, Schlaak JF, Kerr IM. 2003. Differential responses to IFNalpha subtypes in human T cells and dendritic cells. J. Immunol. 171: 5255-5263.
30. Honda K, et al. 2005. IRF-7 is the master regulator of type-I interferondependent immune responses. Nature 434:772-777.
31. Horsfall FL, Curnen EC, Mirick GS, Thomas L, Ziegler JE. 1943. A virus recovered from patients with primary atypical pneumonia. Science 97: 289-291.
32. Horsfall FL, Hahn RG. 1940. A latent virus in normal mice capable of producing pneumonia in its natural host. J. Exp. Med. 71:391- 408.
33. Horsfall FL, Hahn RG. 1939. A pneumonia virus of Swiss mice. Proc. Soc. Exp. Biol. Med. 40:684-686.
34. Horsfall FL, Jr, Curnen EC. 1946. Studies on pneumonia virus of mice (PVM): I. the precision of measurements in vivo of the virus and antibodies against it. J. Exp. Med. 83:25- 42.
35. Horsfall FL, Jr, Curnen EC. 1946. Studies on pneumonia virus of mice (PVM): II. immunological evidence of latent infection with the virus in numerous mammalian species. J. Exp. Med. 83:43- 64.
36. Indraccolo S, et al. 2007. Identification of genes selectively regulated by IFNs in endothelial cells. J. Immunol. 178:1122-1135.
37. Kagiyama N, Takakura A, Itoh T. 1986. A serological survey on 15 murine pathogens in mice and rats. Jikken Dobutsu 35:531-536.
38. Kaplan C, Healing TD, Evans N, Healing L, Prior A. 1980. Evidence of infection by viruses in small British field rodents. J. Hyg. 84:285-294.
39. Kraft V, Meyer B. 1986. Diagnosis of murine infections in relation to test methods employed. Lab. Anim. Sci. 36:271-276.
40. Kraft V, Meyer B. 1990. Seromonitoring in small laboratory animal colonies. A five year survey: 1984-1988. Z. Versuchstierkunde 33:29 -35.
41. Krempl CD, Lamirande EW, Collins PL. 2005. Complete sequence of the RNA genome of pneumonia virus of mice (PVM). Virus Genes 30:237- 249.
42. Krempl CD, et al. 2007. Identification of a novel virulence factor in recombinant pneumonia virus of mice. J. Virol. 81:9490 -9501.
43. Kuiken T, et al. 2003. Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. Lancet 362:263-270.
44. Ling R, Pringle CR. 1989. Polypeptides of pneumonia virus of mice. I. Immunological cross-reactions and post-translational modifications. J. Gen. Virol. 70(Pt 6):1427-1440.
45. Madi A, et al. 2009. Organization of the autoantibody repertoire in healthy newborns and adults revealed by system level informatics of antigen microarray data. Proc. Natl. Acad. Sci. U. S. A. 106:14484 -14489.
46. Manson JJ, Mauri C, Ehrenstein MR. 2005. Natural serum IgM maintains immunological homeostasis and prevents autoimmunity. Springer Semin. Immunopathol. 26:425- 432.
47. McAuliffe J, et al. 2004. Replication of SARS coronavirus administered into the respiratory tract of African Green, rhesus and cynomolgus monkeys. Virology 330:8 -15.
48. Miyata H, et al. 1995. New isolates of pneumonia virus of mice (PVM) from Japanese rat colonies and their characterization. Exp. Anim. 44:95-104.
49. Moro D, Lloyd ML, Smith AL, Shellam GR, Lawson MA. 1999. Murine viruses in an island population of introduced house mice and endemic short-tailed mice in Western Australia. J. Wildl. Dis. 35:301-310.
50. Munir S, et al. 2008. Nonstructural proteins 1 and 2 of respiratory syncytial virus suppress maturation of human dendritic cells. J. Virol. 82: 8780-8796.
51. National Research Council. 1996. Guide for the care and use of laboratory animals. National Academy Press, Washington, DC.
52. Notkins AL. 2004. Polyreactivity of antibody molecules. Trends Immunol. 25:174 -179.
53. Parker SE, Malone S, Bunte RM, Smith AL. 2009. Infectious diseases in wild mice (Mus musculus) collected on and around the University of Pennsylvania (Philadelphia) campus. Comp. Med. 59:424-430.
54. Patterson NA, Smith JL, Ozbun MA. 2005. Human papillomavirus type 31b infection of human keratinocytes does not require heparan sulfate. J. Virol. 79:6838-6847.
55. Pavia AT. 2011. Viral infections of the lower respiratory tract: old viruses, new viruses, and the role of diagnosis. Clin. Infect. Dis. 52 Suppl. 4:S284- S289.
56. Petry H, et al. 2006. Mx1 and IP-10: biomarkers to measure IFN-beta activity in mice following gene-based delivery. J. Interferon Cytokine Res. 26:699 -705.
57. Pringle CR, Eglin RP. 1986. Murine pneumonia virus: seroepidemiological evidence of widespread human infection. J. Gen. Virol. 67(Pt 6):975- 982.
58. Renshaw R, Laverack M, Zylich N, Glaser A, Dubovi E. 2011. Genomic analysis of a pneumovirus isolated from dogs with acute respiratory disease. Vet. Microbiol. 150:88 -95.
59. Ryman KD, Klimstra WB, Johnston RE. 2004. Attenuation of Sindbis virus variants incorporating uncleaved PE2 glycoprotein is correlated with attachment to cell-surface heparan sulfate. Virology 322:1-12.
60. Shay DK, et al. 1999. Bronchiolitis-associated hospitalizations among US children, 1980-1996. JAMA 282:1440 -1446.
61. Skiadopoulos MH, et al. 2003. Determinants of the host range restriction of replication of bovine parainfluenza virus type 3 in rhesus monkeys are polygenic. J. Virol. 77:1141-1148.
62. Smith AL, Singleton GR, Hansen GM, Shellam G. 1993. A serologic survey for viruses and Mycoplasma pulmonis among wild house mice (Mus domesticus) in southeastern Australia. J. Wildl. Dis. 29:219 -229.
63. Spann KM, Tran KC, Chi B, Rabin RL, Collins PL. 2004. Suppression of the induction of alpha, beta, and gamma interferons by the NS1 and NS2 proteins of human respiratory syncytial virus in human epithelial cells and macrophages. J. Virol. 78:4363- 4369.
64. Teng MN, Borrow P, Oldstone MB, de la Torre JC. 1996. A single amino acid change in the glycoprotein of lymphocytic choriomeningitis virus is associated with the ability to cause growth hormone deficiency syndrome. J. Virol. 70:8438-8443.
65. Thorpe LC, Easton AJ. 2005. Genome sequence of the non-pathogenic strain 15 of pneumonia virus of mice and comparison with the genome of the pathogenic strain J3666. J. Gen. Virol. 86:159 -169.
66. van den Hoogen BG, et al. 2001. A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat. Med. 7:719 -724.
67. van der Hoek L, et al. 2004. Identification of a new human coronavirus. Nat. Med. 10:368 -373.
68. van Wyke Coelingh KL, Winter CC, Tierney EL, London WT, Murphy BR. 1988. Attenuation of bovine parainfluenza virus type 3 in nonhuman primates and its ability to confer immunity to human parainfluenza virus type 3 challenge. J. Infect. Dis. 157:655- 662.
69. Woo PC, et al. 2005. Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia. J. Virol. 79:884-895.
70. Yoder SM, Zhu Y, Ikizler MR, Wright PF. 2004. Role of complement in neutralization of respiratory syncytial virus. J. Med. Virol. 72:688-694.
71. Zenner L, Regnault JP. 2000. Ten-year long monitoring of laboratory mouse and rat colonies in French facilities: a retrospective study. Lab. Anim. 34:76-83.
72. Zhang L, Peeples ME, Boucher RC, Collins PL, Pickles RJ. 2002. Respiratory syncytial virus infection of human airway epithelial cells is polarized, specific to ciliated cells, and without obvious cytopathology. J. Virol. 76:5654 -5666.
73. Zhou ZH, et al. 2007. The broad antibacterial activity of the natural antibody repertoire is due to polyreactive antibodies. Cell Host Microbe 1:51- 61.